TPI1
Triosephosphate isomerase
Also known as: TPIS_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60174
- Gene
- TPI1
- Ensembl
- ENSG00000111669
- Chromosome
- 12
- Canonical length
- 249 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme, consisting of two identical proteins, which catalyzes the isomerization of glyceraldehydes 3-phosphate (G3P) and dihydroxy-acetone phosphate (DHAP) in glycolysis and gluconeogenesis. Mutations in this gene are associated with triosephosphate isomerase deficiency. Pseudogenes have been identified on chromosomes 1, 4, 6 and 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
249 residues, UniProt reviewed canonical sequence.
>P60174|TPI1
1 MAPSRKFFVG GNWKMNGRKQ SLGELIGTLN AAKVPADTEV VCAPPTAYID FARQKLDPKI
61 AVAAQNCYKV TNGAFTGEIS PGMIKDCGAT WVVLGHSERR HVFGESDELI GQKVAHALAE
121 GLGVIACIGE KLDEREAGIT EKVVFEQTKV IADNVKDWSK VVLAYEPVWA IGTGKTATPQ
181 QAQEVHEKLR GWLKSNVSDA VAQSTRIIYG GSVTGATCKE LASQPDVDGF LVGGASLKPE
241 FVDIINAKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPI1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 2,316 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 2,316 nTPM
- tongue: 1,874 nTPM
- heart muscle: 689 nTPM
- esophagus: 662 nTPM
- choroid plexus: 622 nTPM
- cerebral cortex: 614 nTPM
Single-cell type
- esophageal apical cells: 5,405 nCPM
- esophageal suprabasal cells: 2,600 nCPM
- extravillous trophoblasts: 2,185 nCPM
- migrating cytotrophoblasts: 1,772 nCPM
- syncytiotrophoblasts: 1,738 nCPM
- esophageal basal cells: 1,695 nCPM
Immune cell
- total PBMC: 4,678 nTPM
- myeloid DC: 2,658 nTPM
- intermediate monocyte: 2,404 nTPM
- eosinophil: 2,381 nTPM
- classical monocyte: 2,308 nTPM
- non-classical monocyte: 2,175 nTPM
Brain region
- cerebral cortex: 473 nTPM
- thalamus: 429 nTPM
- hippocampal formation: 378 nTPM
- cerebellum: 371 nTPM
- basal ganglia: 370 nTPM
- pons: 357 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TPI1.
Disease | AllUniProt
Conditions TPI1 is implicated in, by any mechanism.
- Triosephosphate isomerase deficiency (TPID) MIM:615512
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 180 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Triosephosphate isomerase deficiency
Disease | AutoantibodyPubMed
Conditions in which antibodies against TPI1 are reported. Each links to that disease's full target list.
Showing 0 of 2 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for TPI1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
14 publications
- Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis.
2007 · J Proteome Res · RCR 1.8 · 74 citations - Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
2018 · Oncotarget · RCR 1.4 · 30 citations - Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase.
1993 · Lancet · RCR 1.3 · 39 citations - Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
2009 · Electrophoresis · RCR 1.2 · 45 citations - Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma.
2009 · Cancer Sci · RCR 1.2 · 45 citations
Show 9 more
- Affinity purification of antibodies from sera using polyvinylidenedifluoride (PVDF) membranes as coupling matrices for antigens presented by autoantibodies to triosephosphate isomerase.
1991 · J Immunol Methods · RCR 0.9 · 34 citations - Successful plasmapheresis in corticosteroid-resistant hemolysis in infectious mononucleosis: role of autoantibodies against triosephosphate isomerase.
1992 · Acta Haematol · RCR 0.8 · 22 citations - Autoantibodies against triosephosphate isomerase. A possible clue to pathogenesis of hemolytic anemia in infectious mononucleosis.
1990 · J Exp Med · RCR 0.7 · 20 citations - Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus.
2004 · Biochem Biophys Res Commun · RCR 0.6 · 22 citations - Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection.
1996 · J Med Virol · RCR 0.6 · 19 citations - Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus.
2017 · Clin Rheumatol · RCR 0.6 · 12 citations - Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus.
2006 · J Neuroimmunol · RCR 0.4 · 18 citations - Hemolysis and autoantibodies to triosephosphate isomerase in a patient with acute hepatitis A virus infection.
1994 · Scand J Infect Dis · RCR 0.4 · 9 citations - [Infectious mononucleosis: hemolysis by autoantibodies against triosephosphate isomerase].
1990 · Dtsch Med Wochenschr · RCR 0.2 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0.03
- gnomAD missense Z
- -0.22
- DepMap mean gene effect
- -0.81
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical glycolysis
- gluconeogenesis
- glyceraldehyde-3-phosphate biosynthetic process
- glycerol catabolic process
- glycolytic process
- methylglyoxal biosynthetic process
Molecular functions
- protein homodimerization activity
- ubiquitin protein ligase binding
- methylglyoxal synthase activity
- triose-phosphate isomerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aldolase-type TIM barrel
- Triosephosphate isomerase
- Triosephosphate isomerase, active site
- Triosephosphate isomerase, bacterial/eukaryotic
- Triosephosphate isomerase superfamily
- Triosephosphate isomerase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPI1 as an antibody target. Whether an autoantibody or antibody against TPI1 could matter depends on whether native TPI1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPI1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPI1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...